ABSTRACT The dominant C57BL/10 allele of a single, autosomal, non-H-2 gene (Rfv-3) was found to be required for recovery from viremia and leukemia induced by Friend virus complex in H-2bI b mice. In H-2 a/ a mice, the Rfv-3 gene apparently influenced recovery from viremia in the presence of persistent leukemia because these mice lacked the appropriate H-2 genotype for recovery from leukemia. The Rfv-3 gene was distinct from the Fv-2 gene because recovery from viremia was seen in recombinant-inbred mice with the Fv-2s/s genotype. Furthermore, backcross studies indicated that Rfv-3 and Fv-2 were not linked. The Rfv-3 gene may act by influencing the specific anti-FV humoral antibody response. Friend virus complex (FV) induces the rapid onset of an erythroleukemia in the spleen, bone marrow, blood, and liver of both newborn and adult mice of many strains (1, 2). A number of host genes influence the course of the disease (3). In particular, genes of the major histocompatibility complex (H-2) play a major role in controlling the incidence of spontaneous recovery from established leukemia. The H-2b/b genotype is associated with a high recovery incidence compared to the H-2b/d genotype. This finding was originally demonstrated by Lilly (4) in a backcross population [(C57BL X BALB/c)F1 X C57BL]. Surprisingly, our initial attempts to observe recovery from FV leukemia in inbred strains with the H-2b/b genotype were unsuccessful. The A-BY and BALB.B strains (both H-2 b/b) failed to recover from FV-induced leukemia (5). The C57BL/10 strain (H-2b/b) could not be tested because the presence of the Fv-2r/r genotype in these mice prevented FV-induced splenomegaly (6,7). Only after A.BY or BALB.B mice were crossed with the C57BL/10 strain did we observe a high recovery incidence (5) similar to what had been reported originally by Lilly (4). We surmised that some essential non-H-2 genes from the C57BL/10 strain were present in both the backcross mice and the F1 hybrids and allowed the expression of the H-2b/b-associated recovery trait.
2b/b) suggested that BALB.B mice lacked three or more non-H-2 genes present in C57BL/10 mice that were necessary for the H-2b/b recovery effect (8) . However, in the H-2b/b backcross involving A.BY mice, (C57BL/10 X A.BY)F1 X A.BY, we found that the dominant C57BL/10 allele of a single, autosomal, non-H-2 gene was necessary for H-2b/b-associated recovery from FV leukemia (9) .
In our previous studies (8) of FV-induced leukemia, we also noted that several different F1 hybrid strains were able to recover from the viremia 30-40 days after FV inoculation (8) . Nevertheless, many of these mice had progressive leukemia resulting ultimately in death. Recovery from FV viremia was independent of H-2 type and occurred only in F1 mice that had
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 425 C57BL/10 or a C57BL/10 congenic strain (B1O.A or B1O.D2) as one of the parents; it did not occur in (BALB/c X A)F1 mice (8) . This observation suggested that non-H-2 genes derived from the C57BL/10 mouse were involved in the phenomenon of recovery from FV viremia.
In order to study recovery from FV viremia independently of the H-2 effect on recovery from leukemia, we have examined two congenic backcross populations in which genes other than H-2 were segregating. The results indicated that, in H-2a/a mice, a single non-H-2 gene aappeared to control the recovery from FV viremia in the presence of ongoing leukemia. In H2b/b mice, a single non-H-2 gene also appeared to control recovery from FV viremia, and furthermore there was a strong correlation between recovery from viremia and recovery from leukemia. Thus, the same non-H-2 gene appeared to be responsible for recovery from.both viremia and leukemia in the H-2b/b population and for recovery from viremia in the presence of leukemia in the H-2a/a population. (5) . An increase in spleen size of 3-to 4-fold (>0.4 g) could be detected reliably in this fashion. Mice with enlarged spleens were considered to be leukemic, and persistence of this condition invariably resulted in death.
MATERIALS AND METHODS
Virus. The B-tropic strain of FV was used in all experiments. Virus was propagated, assayed, and stored as described (5) . Mice were bled from the tail or orbit into heparinized tubes, and plasma was assayed for the helper lymphatic leukemia virus (LLV) component of FV on S+L-cells as described (12 (Table 1) . A.BY mice had a high incidence of viremia (82%) and (C57BL/10 X A.BY)F1 mice had a low incidence of viremia (15%). C57BL/10-derived non-H-2 genes appeared to influence recovery from FV viremia in this F1 hybrid also. Therefore, this F1 was backcrossed to A.BY to determine the number of C57BL/10 genes involved: 73 of 169 (43%) of (C57BL/10 X A.BY)F1 X A.BY backcross mice were viremic 30-50 days after FV inoculation. These data indicated that in the H-2b/b backcross a single non-H-2 gene controlled recovery from FV viremia. Because the original H-2a/a and H_2b/b mice used in these experiments were con- were inoculated with FV at 12 weeks of age and were followed for recovery from splenomegaly and FV viremia ( Table 3 ). The litters from two individual mothers (mice 3031 and 3032) were nearly 100% leukemic by palpation. Thus, these mothers had the Rfv-3s/s genotype. Progeny from seven other mothers ranged from 0-60% leukemic and 0-50% viremic 50 days after FV inoculation. These values were not significantly different from the expected value of 50% for progeny of mothers with the Rfv-3'/r genotype. A third backcross to A.BY was also studied, and similar results were obtained (Table 4) . Second-backcross females were randomly selected as mothers from the litters of first-backcross mice shown to have the Rfv-3 /s genotype by progeny testing (Table 3) . Third-backcross litters were obtained from eight mice. Progeny testing indicated that one second-backcross mother had the Rfv-3s/s genotype (mouse 3296), two mothers were not conclusively typed (mice 3294 and 3438), and the remaining five were Rfv-3/rs.
Linkage Data for Rfv-3 Gene. So far we have no information linking the Rfv-3 gene to any known genetic markers in the mouse. Rfv-3 was not observed to be linked to sex, coat color traits (albino, black, agouti), or the Ig-1 locus (14, 15) (Table 3) by crossing these mice with C57BL/10 mice (Fv-2r/r, Rfv-3r/r). If the Rfv-3s/r parent had the Fv-2s/r genotype (i.e., identity or close linkage between Rfv-3 and Fv-2), the progeny from the cross with C57BL/10 (Fv-2r/r) would be 50% susceptible to spleen foci (Fv-2s/T) and 50% resistant (Fv-2r/r). On the other hand, if the Rfv3sl/r parent had the Fv-2818 genotype (i.e., lack of close linkage or identity between Rfv-3 and Fv-2), the progeny from the cross with C57BL/10 would be 100% susceptible to FV spleen foci (Fv-2s/r). Progeny were obtained from seven Rfv-3l/s mice mated to C57BL/10. The offspring from six of these parents had a 100% incidence of spleen foci 9 days after FV inoculation (data not shown). Thus, these six Rfv-3-/s mice had the Fv-2/sl genotype, and Rfv-3 and Fv-2 appeared to be distinct unlinked genes.
We also studied C X B recombinant-inbred mice (10, 11) with the Fv-2/sl genotype. The results indicated that two of the Fv-2s/s C X B strains (C X BE and C X BK) recovered from FV viremia as did the comparable Fv-28/r hybrid (C57BL/10 X BALB.B)F1 (Table 5) r/s 409 r/s 2/4 (50%) 0/4 (0%) * Observed incidence of leukemia and viremia in each group was compared by the x2 test to the expected incidence for the Rfv-33/S genotype and the Rfv-3r/s genotype. Mothers of progeny that could not be definitively typed on a statistical basis are indicated by a question mark before the suspected genotype. DISCUSSION The present results demonstrate the influence of a new gene, Rfv-3, on recovery from FV-induced viremia and leukemia. C57BL/10 and B10.A mice have the Rfv-3r/? genotype, and A/WySn, A.BY, and BALB.B mice have the Rfv-3s/s genotype. F1 or backcross mice with the Rfv-3r/s genotype have a high incidence of recovery from FV viremia 30-40 days after virus inoculation compared to Rfv 3S/S mice. Recovery from viremia is independent of H-2 genotype. In H-2a/a mice, recovery from viremia frequently occurs in the presence of persistent leukemia. However, in H-2b/b mice, recovery from viremia is strongly associated with recovery from leukemia. Thus, the Rfv-3r/s genotype is necessary for expression of H-2b/b-associated recovery from FV leukemia (4, 5, 9, 13) . The data indicate that mechanisms controlled by the Rfv-3 gene are sufficient for control of FV viremia regardless of H-2 genotype and that these mechanisms are necessary but not sufficient for control of FV leukemia. Recovery from leukemia appears to be a more complex phenomenon influenced by at least two separate genes (Rfv-3 and H-2) in the F1 hybrids we have studied. Nongenetic factors also appear to be of major importance because, after inoculation of high FV doses, a significant number (10-30%) of mice fail to recover from FV leukemia even in the (C57BL/10 X A.BY)F1 population in which no genes are segregating. Thus, it was not surprising to observe 35% persistent leukemia among the nonviremic H-2b/b backcross mice because nonviremic mice with persistent leukemia were also seen in the H-2b/b F1 population.
Non-H-2 genetic influences on H-2-associated resistance to leukemia have been demonstrated in two other systems. Tennant and Snell (16, 17) , studying B/T-L virus leukemia, noted a marked difference in incidence of leukemia between two H-2b/b strains (A.BY and C57BL/10). A.BY mice had a high incidence of leukemia (75%) and C57BL/10 had a low incidence (39%). It seems highly likely that this difference might be due at least in part to the Rfv-3 gene, because the same mouse strains were used in our experiments and also B/T-L virus was the helper virus used to produce our FV stock (18) . In the radiation leukemia virus system, Meruelo et al. (19, 20) have shown that H-2-associated resistance to leukemia is influenced by a non-H-2 gene which they called Srlv-1. In this model, susceptibility was a dominant trait because the Srlv-1 r/r genotype was required for demonstration of H-2-associated resistance. Because resistance is dominant for the Rfv-3 gene, it is unlikely that Srlv-1 and Rfv-3 are identical. However, experiments comparing the effects of both FV and radiation leukemia virus on the same mouse populations will have to be done to answer this question conclusively.
Proc. Natl. Acad. Sci. USA 76 (1979) All the inbred mouse strains that have the Rfv-3 /r genotype are also known to have the Fv-2r/l genotype which causes resistance to FV-induced splenomegaly and spleen focus formation (3, 15, 16 At this time we have no conclusive evidence concerning the mechanism of action of the Rfv-3 gene. Rfv-3 theoretically could influence susceptibility to FV-induced immunosuppression (21, 22) as has been demonstrated for the Fv-3 gene (23) . However, Rfv-3 and Fv-3 do not appear to be identical genes because susceptibility to FV-induced immunosuppression is dominant with the Fv-3 gene, whereas recovery from FV viremia is dominant with the Rfv-3 gene. The F1 and backcross mice used in this study should be susceptible to FV-induced immunosuppression (Fv-3f/s or Fv-3/8s); nevertheless, nearly 90% of F1 mice and 50-57% of backcross mice were still able to recover from FV viremia. These results suggest that Fv-3-controlled susceptibility to FV immunosuppression is not involved in the phenomenon of recovery from FV viremia described here.
The Rfv-3 gene could also act by influencing the rate of virus growth via effects on interferon (24) , defective interfering particles (25) , virus-specific cell surface receptors (26) , or the antiviral immune response (8, 27) . The initial observation of a dissociation between recovery from FV viremia and leukemia in certain F1 hybrid mice indicated that recovery from viremia was correlated with the presence of neutralizing anti-FV antibodies in the blood (8) . Although the cause and effect relationship was not proven, it seemed likely that antiviral antibodies were important in elimination of viremia. The Rfv-3 gene may have affected FV viremia by influencing the quality of the specific antiviral immune response in a manner similar to the immune response genes (28) . If 
